A new grant has been awarded by the National Comprehensive Cancer Care Network® (NCCN) Oncology Research Program to a team comprised of PC3I Faculty, Advisors, and Affiliates to increase timely and equitable lung cancer screening (LCS) adherence across diverse populations. Katharine Rendle, PhD, MSW, MPH and Anil Vachani, MD, MSCE will serve as principal investigators alongside co-investigators Peter Gabriel, MD, MSCE; Rebecca Hubbard, PhD; Ravi Parikh, MD, MPP; and Richard Wender, MD.
Adherence to guideline-recommended annual LCS remains low, and disparities exist by race, sex, geography, and socioeconomic status. This grant will test patient and clinician nudge strategies to impact LCS adherence rates, including text messages to patients and electronic health record nudges to clinicians. Analyses will explore how patient, clinician, and system-level factors shape the effectiveness of nudge strategies, both overall and by subgroup. The research will benefit patients directly by identifying strategies to equitably increase LCS adherence.
Further information can be found in the press release by the National Comprehensive Care Network.
The ASCO Annual Meeting 2022 features 20 first- and senior-authored abstracts from Innovation Faculty, Fellows, and staff at the Penn Center for Cancer Care Innovation (PC3I).
The Penn Center for Cancer Care Innovation is proud to announce that PC3I Fellow John Lin, MD, has won a Young Investigator Award from Conquer Cancer, the ASCO Foundation.
This randomized trial leverages peer comparisons to combat physician optimism bias found improved hospice utilization metrics among a group of academic oncologists.